News - lald.org

University of Rochester – Phase 4 Study

University of Rochester Seeks Participants for Final Validation Study of a New Lysosomal Acid Lipase Deficiency (LAL-D) Assessment Tool The...

LIPA c.894G>A: From Patients to Models A study recently accepted for publication in Scientific Reports describes the first mouse model...

“Lipids and Health” Conference: Early Diagnosis, Multidisciplinary Care and Access to Treatment [video width="1080" height="1080"...

“Lipids and Health” Conference Next June 30 at 5:00 p.m., Cardioalianza, LAL-D Patient Organization, ASCAHIFA and Asociación Síndrome...

EASL Congress 2026: Barcelona at the heart of hepatology From May 26–29, Barcelona hosted the EASL Congress 2026, one of the leading...

LAL-D Patient Organization Joins CardioAlianza On May 20, 2026, during the General Assembly of CardioAlianza held in Valencia, the incorporation...

A new publication in Hepatology International provides important evidence about the role of lysosomal acid lipase (LAL) in liver disease...

The National Federation of Liver Patients and Transplant Recipients (FNETH), part of COCEMFE, is running in 2026 the project “Accede Público...

LAL‑D Study – Phase 3 the University of Rochester (USA) is currently conducting Phase 3 of its research project on Lysosomal Acid Lipase...

Genetic liver diseases: rare, but clinically highly relevant This article highlights that genetic liver diseases, while individually uncommon,...

en‑LISOS Journal – Issue No. 9, March 2026 en‑LISOS has published its Issue 9 (March 2026), featuring scientific and informative content focused...

12th Interdisciplinary Conference on Advances in Rare Diseases On March 6, we took part in the 12th Interdisciplinary Conference on Advances in...